Clinical trial

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

NCT07086443

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-07-11

PhasePHASE4

Study timeline

Study start (actual)2025-07-11Date precision: day

Registry last updated2026-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Foot Ulcerunresolved

DFUunresolved

Diabetic Foot Ulcer (DFU)unresolved

Foot Ulcer Due to Type 1 Diabetes Mellitusunresolved

Foot Ulcer Due to Type 2 Diabetes Mellitusunresolved

Ulcerunresolved

Ulcer Footunresolved

Interventions

Activate™ MatrixOTHER

AmnioDefend™ FT MatrixOTHER

Palisade™ DM MatrixOTHER

Enclose™ TL MatrixOTHER

Sentry™ SL MatrixOTHER

Shelter™ DM Matrix + SOCOTHER

Sponsors & collaborators

Sequence LifeScience, Inc.lead sponsor

Serena Groupcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07086443 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.